Introduction
When suffering from acute or chronic diseases, overweight or mild obesity patients have better outcomes than those with normal weight; this phenomenon has been referred to as 'obesity paradox' and reported in a variety of diseases, e.g. heart failure, 1, 2 myocardial infarction, 3 stroke, 4 diabetes, 5 chronic kidney disease, 6 etc. However, not all studies supported the relation. 7 Body mass index (BMI), a universally used index for measuring obesity, might be criticized for the controversial findings. 8 Body composition includes fat mass, muscle, skeleton and body fluid, whereas BMI does not differentiate lean mass from fat mass. With the sum of the skinfold method, Lavie et al. 9 showed that both of higher body fat (BF) and higher lean mass predicted survival advantage in patients with stable coronary artery disease (CAD) from a US cohort. As obese Chinese are characterized by predominantly abdominal obesity 10 and nasty metabolic abnormalities, 11 whether BF or less mass is associated with favorable prognosis in Chinese patients with CAD is unknown. Thus, the aim of this study was to investigate the association between body composition and all-cause mortality in a Chinese population with CAD.
Materials and methods

Subjects
All patients undergoing coronary angiography at West China hospital, Sichuan University, were consecutively recruited. Baseline characteristics were collected and entered into a dedicated database (Coronary Heart Disease Database). The database has been described in detail before. 12 All patients included in the study had angiographic evidence of at least one major epicardial coronary artery with stenosis ! 50%. Exclusion criteria included lack of anthropometric data, malignancies, severe hepatic disease and severe hemorrhagic disease. The study was approved by the local ethics committee and all participants gave written informed consent.
Body composition assessment
During the period of hospitalization, body height and weight of the patients were measured by experienced nurses with standard methods. BMI was the ratio of weight to height.
2 BF was estimated using the Clínica Universidad de Navarra-Body Adiposity Estimator (CUN-BAE) equation 13 : BF% = À44.988 + (0.503 x age) + (10.689 x sex) + (3.172 x BMI) À(0.026 x BMI 2 ) + (0.181 x BMI x sex) À (0.02 x BMI age) À (0.005 x BMI 2 x sex) + (0.00021 x BMI 2 x age), where male is 0 and female is 1. The formula has been validated in a large population with good consistency with actual BF%. Lean mass index (LMI) was calculated as: LMI = (1 À BF) x BMI, kg/m 2 . 9 As no reference value has been recommended for Chinese population, we divided the study patients into four groups according to the quartiles of LMI: Quartile 1 (<16 kg/m 2 ); Quartile 2 (16-17.6 kg/m 2 ); Quartile 3 (17.6-18.6 kg/m 2 ) and Quartile 4 (!18.6 kg/m 2 ).
Baseline characteristics and outcomes
Cardiovascular risk factors, medical history, vital signs, clinical features, laboratory indices, angiographic findings and medications at discharge were collected by chart review or personal interview. The primary endpoint of the study was all-cause mortality. Patients were followed-up by telephone interview, medical chart review or outpatients visit. The events were authenticated by medical records or the immediate family of the patients.
Statistics
Continuous variables were expressed as mean AE standard deviation, whereas categorical variables were presented as absolute value (percentage). Comparisons of baseline characteristics across groups stratified by LMI quartiles were conducted using one-way analysis of variance for continuous variables and chi-square test for categorical variables. Univariate Cox regression analyses were performed to test the variables correlated to all-cause mortality. Predictors of the outcome with statistical significance (P < 0.1) in univariate analyses were further entered into multivariate Cox regression analyses. The results were presented as relative risk, hazard ratio (HR) and 95% confidence interval (CI). Cox regression plot was constructed to show the probability of free from mortality by quartiles of LMI. Two-sided P value < 0.05 indicated significant. The statistical analyses were performed with PASW Statistics 18.0 software (SPSS Inc., Chicago, IL).
Results
During the period between July 2008 and September 2012, a total of 3714 participants diagnosed with CAD and validated by coronary angiography were included into the database. Of these patients, 347 (9.3%) lost to follow-up and 72 (1.9%) with incomplete follow-up data were excluded. Further screening excluded 15 patients (0.4%) without anthropometric data. Finally, 3280 patients were included into the study.
The baseline characteristics across LMI quartiles are demonstrated in Table 1 . Patients with higher LMI were significantly younger, more male and current smokers, had less BF and comorbidities (hypertension and diabetes). Systolic blood pressure was lower, while diastolic blood pressure was higher in participants with higher LMI. The level of serum creatinine, white blood cell count and haemoglobin were higher in the higher LMI quartiles. Secondary prevention drugs were prescribed more often in patients with higher LMI.
During a median time of 24 months, 288 (8.8%) patients died from any cause. A gradually reduced trend of mortality rate was observed across increasing quartiles of LMI (Quartile (Q) 1 vs. Q2 vs. Q3 vs. Q4: 12.5% vs. 9.6% vs. 7.7% vs. 5.3%, P < 0.001). Univariate Cox regression analyses showed that highest quartile of LMI (HR: 0.40, 95% CI: 0.28-0.57), together with previous percutaneous coronary intervention, current smoking, higher diastolic blood pressure, higher level of haemoglobin, higher left ventricular ejection fraction (LVEF) and medication at discharge were protective factors with regard to mortality, whereas older age, diabetes, faster heart rate, higher level of creatinine, glucose and white blood cell count and complicated coronary artery lesions were associated with increased risk of allcause mortality. Highest quartile of BF did not 
Discussion
The inconsistent findings regarding to obesity paradox have raised the concern about the defect of BMI in measuring obesity. To our knowledge, this study firstly investigated the relationship between body composition and outcomes in a prospective Chinese cohort with CAD. Our results showed that higher lean mass, but not BF, was associated with lower all-cause mortality rate. The debates on obesity paradox continued. Although the paradoxical association has been reported in CAD patients from Japan 14 and Korea, 15 studies from China 16, 17 did not show the relationship. As all the three countries are located in East Asia, differences in race, somatotype and lifestyle are relatively small. Divergences of the findings might be attributed to the most fundamental issue-inaccurate measurement of obesity with BMI. With the advantages of simplicity and easy availability, BMI has been widely used in assessing obesity. However, body composition undergoes time-varying changes in one's lifetime, and the proportions of fat mass and non-fat mass are disparate in women and men. As such, BMI lacks the ability of exactly appraising BF in a given patient. In recent years, studies about obesity paradox have focused on the association between body composition and outcomes. Lavie et al. 9 from the United States assessed BF and calculated LMI by the sum of the skinfold method in 570 patients with stable coronary heart disease. The study demonstrated that both higher BF and higher LMI independently predicted survival benefit. In another study comprising 47 866 patients with preserved LVEF referred for echocardiography, the significance of LMI was stressed. 18 In that study, BF was a protective factor for survival in the lean patients through interplay with LMI but not in the obese patients, whereas LMI protected patients from mortality in both lean and obese patients, independently of BF. In a prospective study of elderly Koreans, Han et al. 19 showed that higher LMI independently predicted better survival; however, no association was found between BMI, BF and mortality.
Obesity benefits patients with CAD in several ways. Obese patients search for secondary prevention drugs more actively; obesity implies a good nutrient reserve status; several factors secreted by adipose tissue exert anti-inflammation effects and the event rate of malignant arrhythmia might be reduced in obese patients. 20, 21 Nevertheless, the harm related to obesity must bear in mind. After all, it is not unusual that obese patients are concomitant with clustered cardiovascular risk factors. Obese Chinese patients demonstrated several differences from their counterparts in Western countries. Abdominal obesity is more predominant in Asian obese population 10 ; meanwhile, they are more liable to suffer from insulin resistance. 22 Furthermore, although obese population without severely metabolic disturbances, also called as 'benign obesity', carried similar risk of mortality and cardiovascular morbidity in comparison with subjects with normal-fat and healthily metabolic status in a US cohort, 23 REACTION study from China did not observed event-free superiority in 'benign obesity' (insulin-sensitive obesity). 24 In this study, no association was detected between BF and mortality-it was supposed that benefits brought by obesity might be offset by its disadvantages, which were particularly evident in obese Chinese, or BF did not identify the distribution of fat mass in the body, which carried distinct clinical significance.
The prognostic value of lean body mass has been shown in a broad population. 25 A study of 18 033 male veterans showed that, the association between low BMI levels and high mortality risk was apparent only in those without high-fitness participants, indicating that worse outcomes of lower BMI in 'obesity paradox' might be attributed to insufficiency of lean body mass. 26 In a study with relatively small sample size, 27 higher fat-free mass index has been shown to be associated with fewer in-hospital complications and better survival outcome in patients receiving cardiac surgery, consistent with others findings. 28 As lean body mass prompts cardiopulmonary function and exercise performance, it is easy to understand that CAD patients with greater LMI have better prognosis than those with less LMI. On the contrary, low lean mass is associated with physical inactivity, indicators of inflammation and coagulation, predisposing patients to great risk of adverse cardiovascular events. 29 This study suggested that for the management of patients with CAD, more attention should be paid on the nutritional supplements and cardio exercise, with the hope of increasing lean mass, improving cardiopulmonary efficacy and prolonging lifespan.
Study limitations should be acknowledged. First, although this study focused on the association between body composition and mortality in patients with CAD, BF and lean mass were not directly measured. As skin fold analyzer, bioelectrical impedance method and dual energy X-ray absorptiometry estimate BF more acutely, further investigations with these methods are urgently needed. Nevertheless, CUN-BAE equation used here has been derived from a large sample with broad range of age and body adiposity, besides it has been validated in other large cohorts. Body composition is readily to access with the equation in clinic. Furthermore, changes of body composition after incident coronary events or during follow-up were not investigated in this study. In addition, fluid retention as the consequence of heart failure was not assessed in the included patients, which affected the measurement of BMI and body composition. However, ejection fraction was comparable across groups, reducing the biases to some extent. Lastly, as an observational study, residual confounders not fully adjusted might deviate the results from the true condition.
In conclusion, in Chinese population with CAD, less lean body mass, but not BF is associated with higher mortality rate. Increasing lean body mass with nutrition and excise is needed and looks promising.
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